iHridAI

India Founded: 2021 • Age: 5 yrs
AI platform for analyzing cardiac MRI scans using deep learning for faster healthcare diagnostics.

About iHridAI

iHridAI is a Technology company based in India founded in 2021. It operates as an AI platform for analyzing cardiac MRI scans using deep learning for faster healthcare diagnostics. It operates on a SaaS model in Technology and Healthcare sectors. Its Indian entity Ihridai Software Private Limited reported revenue of β‚Ή6.1 Lakh. iHridAI offers products and services including HarmonyCVI and AI Powered Cardiovascular MRI Analysis Tool. Its focus areas include AI in Healthcare, Medical Imaging, Cardiac MRI Analysis and Analytics Solutions. Its competitors include Artrya, Qianglian Zhichuang, PrediSurge, Saigeware Technologies and x-cardiac and 4 more; 5 of its 9 listed competitors have raised funding.

Company details

iHridAI is an AI platform that leverages deep learning to analyze cardiac medical imaging, enhancing the speed, quality, and efficiency of medical diagnoses. It offers cloud-based solutions for healthcare organizations, automating cardiovascular MRI analysis without manual intervention. Based in the USA, it serves clinicians by providing quick insights and precise quantification, ultimately improving patient outcomes and care delivery.

  • Headquarters India
  • Employees 1
  • Sectors
    Technology
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website ihridai.com
  • Social X Facebook
  • Legal Name Ihridai Software Private Limited
  • Date of Incorporation 13 Oct, 2021
  • Jurisdiction Hyderabad, Telangana, India
Key Metrics
  • Annual Revenue
    ₹6.1 Lakh

    FY 2025

  • Net Profit
    ₹1.1 Lakh

    FY 2025 · 18% margin

  • EBITDA
    ₹1.3 Lakh

    FY 2025 · 22% margin

  • Employee Count
    1

Products & Services of iHridAI

iHridAI offers a comprehensive portfolio of products and services, including HarmonyCVI and AI Powered Cardiovascular MRI Analysis Tool.

HarmonyCVI
Cardiac Imaging Software

Platform for automatic analysis of cardiovascular MRI scans

AI Powered Cardiovascular MRI Analysis Tool
Diagnostic Platform

Tool for enhancing accuracy in cardiac imaging diagnostics

Board of directors of Ihridai Software Private Limited (iHridAI)

Ihridai Software Private Limited is the primary company behind iHridAI. The board of Ihridai Software Private Limited currently have 2 directors; the longest-serving is Sai Sridhar Sangineni, appointed in 2021.

DirectorDesignationAppointedTenureEntity
Sai Sridhar Sangineni
DIN 03274134
Director13 Oct 20215 yrsIhridai Software Private Limited
Jeevendran Vimal Raj
DIN 07513644
Director13 Oct 20215 yrsIhridai Software Private Limited

Financials of iHridAI

Figures of Ihridai Software Private Limited, the primary company behind iHridAI, for FY 2025. Revenue was ₹6.1 Lakh. Net profit was ₹1.1 Lakh (18% margin). EBITDA was ₹1.3 Lakh (22% margin).

  • ₹6.1 LakhRevenue · FY 2025
  • ₹1.1 LakhNet profit · 18% margin
  • ₹1.3 LakhEBITDA · 22% margin
  • ₹10 LakhPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Ihridai Software Private Limited are on its company page.

Premium access

Detailed financial statements for iHridAI

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of iHridAI

iHridAI has 9 listed competitors in our database, 5 of them funded. They include Artrya, Qianglian Zhichuang, PrediSurge, Saigeware Technologies and x-cardiac, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
artrya.com2018Perth, Australia––
AI-based cardiovascular analysis tools are provided to healthcare providers.
unionstrongtech.com2016Beijing, China––
AI-driven solutions for cerebrovascular disease diagnosis and treatment are developed.
predisurge.com2017Saint Etienne, France$8.51M–
Provider of decision making tools for cardiologists
saigeware.com2019Bengaluru, India$256,137–
AI-based decision support tool for cardiac and pulmonary practices
xcardiac.com2019Berlin, Germany––
An AI-based cardiac diagnosis tool is provided for healthcare professionals.
topspin.co.il1999Lod, Israel$24.5M–
Develops intravascular MRI catheters for coronary artery applications.
creavomedtech.com2014Leeds, United Kingdom$17.84M17
Offers digital devices for cardiology health management and monitoring tailored to healthcare providers.
capical.de2010Braunschweig, Germany–5
ECG devices utilizing capacitive electrodes are developed by Capical.
waferchips.co.in2015Kollam, India$116,760–
Platform for monitoring early cardiac symptoms in patients is provided.
Premium access

Detailed competitors of iHridAI

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in AI in Medical Diagnostics

10 companies that operate in the same segment as iHridAI (AI in Medical Diagnostics), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Early-stage investments in digital, climate, and deep science technologies.
2011Mumbai, Maharashtra, India–USD 1.11 M–
Deep tech innovation in IoT and AI for startups and enterprises in India.
2015Bengaluru, Karnataka, India–––
Creates AI technologies for surgical planning, robotics, and cloud-based tools.
2018Mumbai, Maharashtra, IndiaUSD 120 K––
Health services are provided via cordys.health domain.
2022NetherlandsUSD 947.57 K––
Offers AI-powered digital solutions, engineering, IT services, and talent management globally.
1992Bengaluru, Karnataka, India–USD 108.7 M3,441
Offers AI consulting, data analytics, and product engineering for various industries.
2014Ghaziabad, Uttar Pradesh, India–USD 1.4 M55
An AI-powered tool for analyzing chest X-rays to support COVID interventions.
2021Bengaluru, Karnataka, India–USD 177.48 K24
Provides data-driven health optimization, diagnostics, and AI care for individuals and businesses.
2016Bengaluru, Karnataka, India–USD 508.49 K31
Venture capital investing in European HealthTech innovators for healthcare advancements.
2021Munchen, Bayern, Germany–––
Provides medical imaging analysis for clinical trials using AI and secure data processing.
2012Bengaluru, Karnataka, India–USD 487.68 K–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Ihridai

Premium access

Complete news archive for iHridAI

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about iHridAI

iHridAI was founded in 2021.

iHridAI is headquartered in India.

iHridAI has 1 employees.

The primary company behind iHridAI, Ihridai Software Private Limited, reported revenue of β‚Ή6.1 Lakh for FY 2025.

iHridAI is an AI platform that leverages deep learning to analyze cardiac medical imaging, enhancing the speed, quality, and efficiency of medical diagnoses. It offers cloud-based solutions for healthcare organizations, automating cardiovascular MRI analysis without manual intervention. Based in the USA, it serves clinicians by providing quick insights and precise quantification, ultimately improving patient outcomes and care delivery.

iHridAI's top competitors include Saigeware Technologies, Artrya and x-cardiac.

iHridAI offers HarmonyCVI and AI Powered Cardiovascular MRI Analysis Tool.

iHridAI operates through Ihridai Software Private Limited.

The legal entities of iHridAI currently have 2 directors, including Sai Sridhar Sangineni, Jeevendran Vimal Raj.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available